[drug report] atorvastatin calcium Drug Report

Atorvastatin calcium was developed by Pfizer, approved by FDA on December 17, 1996, and approved by PMDA on March 10, 2000 The drug was listed and sold in Japan by Pfizer and astralas under the trade name Lipitor Contents 1) Abstract Information 2) API information 3) pharmacological action 4) listing in the United States (10 articles) 5) listing in the European Union (80 articles) 6) major listed companies (101 articles) 7) listing in China (58 articles) 8) registration and application in China (349 articles) 9) drug standards (22 articles) 10) drug instructions (7 articles) 11) global clinical trials (18 articles) 12) patent status in the United States (2 articles) 13) more global R & D information (3 articles) 1) Information 2) API information structure formula: Chemical Name: (β R, δ R) - 2 - (p-fluorophenyl) - β, δ - dihydroxy-5-isopropyl-3-phenyl-4 - (phenylcarbamoyl) mirror-1-heptanocacid, Calciumsalt (2:1) CAS Registration No.: 134523-03-8 molecular formula: c66h68caf2n4o10 molecular weight: 1155.341723) pharmacological category: cardiovascular system > lipid regulator > lipid regulator, single prescription > β - hydroxy - β - methylglutaryl CoA reductase inhibitor 4) listing in the United States (10 articles) listing in the European Union (80 articles) Note: due to the huge amount of data, only 6 items are listed here 6) Note to major listed companies (101): due to the huge amount of data, only 10 are listed here 7) China listing (58 items) Note: due to the huge data, only 10 items are listed here 8) China's registration application (349 articles) Note: due to the huge data space, only 10 articles are listed here 9) Drug standards (22 articles) 10) drug instructions (7 articles) 11) global clinical trials (18 articles) 12) U.S patent status (2 articles) 13) more global R & D information (3 articles) data sources: due to the huge length of the report, we will not elaborate one by one here If you want to get the full text of the report, you can click "Pharma global drug R & D database" to view it Original statement: This article is the original manuscript of yaozhi.com, welcome to reprint, reprint please indicate the source, thank you!